extended-release

The Difference in Guanfacine Formulations for ADHD

By: Katharine Cimmino, Editor-in-Chief - Attention-deficit/hyperactivity disorder (ADHD) is the most common pediatric psychiatric disorder, and it affects the education,…

12 years ago

Two New Agents for the Treatment of Obesity

By: Nathan Trustman, PharmD Candidate c/o 2013, AMSCOP at LIU - Obesity is defined as having a body mass index…

13 years ago

Bydureon®: A Weekly Injection for Type 2 Diabetes Mellitus

By: Mohamed Dungersi - On January 27, the FDA approved Bydureon® (exenatide extended-release) for use in Type 2 Diabetes Mellitus…

14 years ago